[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342230-105":59,"doc-detail-342230-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cd69-cd103-cd8-tissue-resident-memory-t-cells-possess-stronger-anti-tumor-activity-and-predict-better-prognosis-in-colorectal-cancer","CD69+ CD103+ CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer","","Colorectal cancer (CRC) remains highly lethal despite therapeutic advances, and CD8+ tissue-resident memory T (TRM) cells—positioned to drive anti-tumor immunity—show marked heterogeneity in surface markers and functions. This study compares CD8+ TRM subsets in clinical CRC samples with bioinformatics and in vitro assays to define subset roles, identify synergistic signaling pathways, and predict key transcription factors. Results distinguish CD69−CD103−, CD69+CD103−, and CD69+CD103+ subsets, with DP CD8+ TRM cells offering stronger protective activity and better prognosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cd69-cd103-cd8-tissue-resident-memory-t-cells-possess-stronger-anti-tumor-activity-and-predict-better-prognosis-in-colorectal-cancer/342230/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cd69-cd103-cd8-tissue-resident-memory-t-cells-possess-stronger-anti-tumor-activity-and-predict-better-prognosis-in-colorectal-cancer/342230.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What CD8+ TRM subsets are identified in colorectal cancer tumor tissues?","Question",{"text":112,"@type":113},"The study identifies CD69−CD103−CD8+ TRM, CD69+CD103−CD8+ TRM (SP), and CD69+CD103+CD8+ TRM (DP) subsets in CRC tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do DP CD8+ TRM cells relate to prognosis and anti-tumor effects?",{"text":117,"@type":113},"Increased infiltration of DP CD8+ TRM cells predicts better prognosis and provides protection, mainly through limiting tumor invasion and lymph node metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms make DP CD8+ TRM cells stronger anti-tumor responders?",{"text":121,"@type":113},"DP CD8+ TRM cells express higher effector molecule levels and act in a FAS/FASL pathway-dependent manner, and they secrete CXCL13 to recruit B cells via the CXCL13/CXCR5 axis to form tertiary lymphoid structures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342230,1790194228,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wu et al. Cell Communication and Signaling (2024) 22:608  \n[https://doi.org/10.1186/s12964-024-01990-3](https://doi.org/10.1186/s12964-024-01990-3)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nCD69+ CD103+ CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer  \nZi-Xin Wu 1†, Tian-Tian Da2†, Chuan Huang2, Xiao-Qing Wang2, Liang Li2, Zhi-Bin Zhao2, Ting-Ting Yin 1, Hai-Qing Ma2, Zhe-Xiong Lian2, Jie Long2*, Fei Wang3* and Jie Cao 1*  \nAbstract  \nBackground Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. Despite advancements in therapeutic methodologies, it still causes a high rate of patient mortality. CD8+ tissue-resident memory T (TRM) cells are strategically positioned to mediate effective anti-tumor responses. However, the characteristic surface molecules and functions of CD8+ TRM cells exhibit significant heterogeneity.  \nMethods The roles and anti-tumor biological functions of different CD8+ TRM subsets in CRC were determined by clinical CRC samples, bioinformatics analysis, and in vitro experiments including co-culture experiments and transwell migration assays. The signaling pathways that synergistically regulate the differentiation of CD8+ TRM cells were identified by in vitro CD8+ T cell activation and inhibition assays, and the functioning transcription factors were predicted using the UCSC and JASPAR databases.  \nResults We found that different CD8+ TRM subsets existed in CRC tumor tissues, which were identified as  \nCD69 − CD103 − CD8+ TRM, CD69+CD103 − CD8+ TRM (SP CD8+ TRM), and CD69+CD103+CD8+ TRM (DP CD8+ TRM) subsets. Compared with SP CD8+ TRM cells, increased infiltration of DP CD8+ TRM cells predicted better prognosis and played a protective role mainly in tumor invasion and lymph node metastasis of CRC. DP CD8+ TRM cells expressed higher levels of effector molecules and exerted stronger anti-tumor effects in a FAS/FASL pathway-dependent manner. Additionally, DP CD8+ TRM cells secreted higher levels of CXCL13 and recruited B cells into tumor tissues through the CXCL13/CXCR5 signaling axis to form tertiary lymphoid structures, participating in anti-tumor immune responses. Notch and TGF-β signaling pathways synergistically regulate the differentiation of DP CD8+ TRM cells.  \n†Zi-Xin Wu and Tian-Tian Da contributed equally to this work.  \n*Correspondence:  \nJie Long [lj9358@mail.ustc.edu.cn](lj9358@mail.ustc.edu.cn)[ ](lj9358@mail.ustc.edu.cn)Fei Wang [wangfei11194343@163.com](wangfei11194343@163.com)[ ](wangfei11194343@163.com)Jie Cao [eycaojie@scut.edu.cn](eycaojie@scut.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nWu et al. Cell Communication and Signaling (2024) 22:608 Page 2 of 17  \nConclusions We clarified the roles and mechanisms of different CD8+ TRM subsets in CRC and identified that DP CD8+ TRM cel","cbCairQxYTgZvEKT","https://ap.wps.com/l/cbCairQxYTgZvEKT","pdf",9995091,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background\n## Clinical context and treatment limitations\n## TRM cell biology in tumors","[{\"question\":\"What CD8+ TRM subsets are identified in colorectal cancer tumor tissues?\",\"answer\":\"The study identifies CD69−CD103−CD8+ TRM, CD69+CD103−CD8+ TRM (SP), and CD69+CD103+CD8+ TRM (DP) subsets in CRC tissues.\"},{\"question\":\"How do DP CD8+ TRM cells relate to prognosis and anti-tumor effects?\",\"answer\":\"Increased infiltration of DP CD8+ TRM cells predicts better prognosis and provides protection, mainly through limiting tumor invasion and lymph node metastasis.\"},{\"question\":\"What mechanisms make DP CD8+ TRM cells stronger anti-tumor responders?\",\"answer\":\"DP CD8+ TRM cells express higher effector molecule levels and act in a FAS/FASL pathway-dependent manner, and they secrete CXCL13 to recruit B cells via the CXCL13/CXCR5 axis to form tertiary lymphoid structures.\"}]","CD69+ CD103+ CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer | PDF",1790045856,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc52227c85db3fca2f2be272e71635e4.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5136de982a98fa4ccf841641af95732.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de6d134b66e5f67d44999d6ac9082f21.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87cc04a710883e7a1a695fb771804dd9.webp",980,1306]